Published in Vaccine Weekly, May 6th, 1996
SmithKline Beecham Biologicals executives briefing the press at the center's formal launch said the company was developing a treatment that would protect against six diseases in one and which the company considered one of its most exciting products. The six diseases are diptheria, tetanus, whooping cough, hepatitis B, haemophilus influenzae (which can produce meningitis in children), and polio.
Further research seeks to include protection against Hepatitis A. "In principle, the main...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.